Your browser doesn't support javascript.
loading
Bearing 19q13 aberration predicts poor prognosis in non-germinal centre type of CD5+ DLBCL.
Mishima, Yuko; Terui, Yasuhito; Yokoyama, Masahiro; Nishimura, Noriko; Ueda, Kyoko; Kusano, Yoshiharu; Yamauchi, Hirofumi; Inoue, Norihito; Takahashi, Anna; Tsuyama, Naoko; Mishima, Yuji; Takeuchi, Kengo; Hatake, Kiyohiko.
Afiliación
  • Mishima Y; Department of Haematology Oncology, The Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Terui Y; Division of Clinical Research, The Cancer Chemotherapy Centre, Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Yokoyama M; Department of Haematology Oncology, The Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Nishimura N; Division of Clinical Research, The Cancer Chemotherapy Centre, Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Ueda K; Department of Haematology Oncology, The Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Kusano Y; Department of Haematology Oncology, The Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Yamauchi H; Department of Haematology Oncology, The Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Inoue N; Department of Haematology Oncology, The Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Takahashi A; Department of Haematology Oncology, The Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Tsuyama N; Department of Haematology Oncology, The Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Mishima Y; Department of Haematology Oncology, The Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Takeuchi K; Division of Pathology, The Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Hatake K; Division of Clinical Research, The Cancer Chemotherapy Centre, Japanese Foundation for Cancer Research, Tokyo, Japan.
Br J Haematol ; 183(4): 661-664, 2018 11.
Article en En | MEDLINE | ID: mdl-29076146
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Cromosomas Humanos Par 19 / Aberraciones Cromosómicas / Linfoma de Células B Grandes Difuso / Antígenos CD5 / Proteínas de Neoplasias Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Male / Middle aged Idioma: En Revista: Br J Haematol Año: 2018 Tipo del documento: Article País de afiliación: Japón
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Cromosomas Humanos Par 19 / Aberraciones Cromosómicas / Linfoma de Células B Grandes Difuso / Antígenos CD5 / Proteínas de Neoplasias Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Male / Middle aged Idioma: En Revista: Br J Haematol Año: 2018 Tipo del documento: Article País de afiliación: Japón